ACW.AX
Price:
$0.035
Market Cap:
$125.60M
Actinogen Medical Limited is an Australian biotechnology company dedicated to developing treatments for neurological and neuropsychiatric disorders linked to imbalanced brain cortisol levels. Their lead product, Xanamem, an inhibitor of the 11ß-HSD1 enzyme, is currently in Phase 2 clinical trials. This compound has demonstrated target engagement within the central nervous system and is being investigated for its potential in conditions such as Alzheimer's disease, depression with cognitive impairment, and the anxiety, sleep, and behavioral issues associated with fragile X syndrome. Founded in 1999, the company was formerly known as Actinogen Limited, adopting its current name in November 201...[Read more]
Industry
Biotechnology
IPO Date
2007-10-16
Stock Exchange
ASX
Ticker
ACW.AX
According to Actinogen Medical Limited’s latest financial reports and current stock price. The company's current PE Ratio is -3.50. This represents a change of -56.16% compared to the average of -7.98 of the last 4 quarters.
The mean historical PE Ratio of Actinogen Medical Limited over the last ten years is -11.13. The current -3.50 PE Ratio has changed 3.04% with respect to the historical average. Over the past ten years (40 quarters), ACW.AX's PE Ratio was at its highest in in the December 2024 quarter at -0.02. The PE Ratio was at its lowest in in the June 2021 quarter at -34.65.
Average
-11.13
Median
-7.76
Minimum
-46.02
Maximum
-1.03
Discovering the peaks and valleys of Actinogen Medical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 911.19%
Maximum Annual PE Ratio = -1.03
Minimum Annual Increase = -80.68%
Minimum Annual PE Ratio = -46.02
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -4.65 | -57.06% |
| 2024 | -10.83 | 63.90% |
| 2023 | -6.61 | -25.86% |
| 2022 | -8.92 | -80.63% |
| 2021 | -46.02 | 911.19% |
| 2020 | -4.55 | 339.73% |
| 2019 | -1.03 | -80.68% |
| 2018 | -5.36 | -53.35% |
| 2017 | -11.49 | -3.06% |
| 2016 | -11.85 | 119.71% |
The current PE Ratio of Actinogen Medical Limited (ACW.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.37
5-year avg
-15.41
10-year avg
-11.13
Actinogen Medical Limited’s PE Ratio is greater than Recce Pharmaceuticals Ltd (-4.87), greater than Alterity Therapeutics Limited (-6.28), greater than Arovella Therapeutics Limited (-10.11), less than Imugene Limited (-0.47), greater than Island Pharmaceuticals Limited (-12.31), less than EZZ Life Science Holdings Limited (9.03), less than Biome Australia Limited (62.27), less than SDI Limited (13.96), greater than Starpharma Holdings Limited (-90.75), greater than PainChek Limited (-3.80),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.87 | $147.48M | |
| -6.28 | $97.88M | |
| -10.11 | $80.99M | |
| -0.47 | $39.50M | |
| -12.31 | $87.52M | |
| 9.03 | $26.11M | |
| 62.27 | $61.56M | |
| 13.96 | $161.66M | |
| -90.75 | $294.65M | |
| -3.80 | $27.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actinogen Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Actinogen Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Actinogen Medical Limited's PE Ratio?
How is the PE Ratio calculated for Actinogen Medical Limited (ACW.AX)?
What is the highest PE Ratio for Actinogen Medical Limited (ACW.AX)?
What is the 3-year average PE Ratio for Actinogen Medical Limited (ACW.AX)?
What is the 5-year average PE Ratio for Actinogen Medical Limited (ACW.AX)?
How does the current PE Ratio for Actinogen Medical Limited (ACW.AX) compare to its historical average?